Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • HyperFluor 488 Goat Anti-Human IgG: Precision in Immunofluor

    2026-05-07

    HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody: Comprehensive Dossier for Advanced Immunodetection

    Executive Summary: HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody (SKU K1205, APExBIO) is an affinity-purified, polyclonal secondary antibody that targets human immunoglobulin G heavy and light chains. It is conjugated to Alexa Fluor 488, excitable at 495 nm and emitting at 519 nm for sensitive fluorescence detection (source: product_spec). The antibody is optimized for applications including Western blotting, immunofluorescence, immunohistochemistry, flow cytometry, and ELISA, with minimal cross-reactivity due to rigorous immunoaffinity purification (source: internal_article). Provided as a stabilized liquid at 1 mg/mL with 23% glycerol and preservatives, it remains stable for at least 12 months at -20°C when protected from light (source: product_spec). The robust Alexa Fluor 488 conjugation ensures high signal amplification and low background, empowering researchers in high-sensitivity immunodetection workflows (source: internal_article).

    Biological Rationale

    Secondary antibodies targeting human IgG are fundamental in immunoassays for the detection of endogenous or vaccine-induced antibodies. In translational research and vaccine studies, precise quantification of humoral responses is required to assess both baseline and induced immunity, especially during preclinical evaluations of novel immunogens such as bivalent mRNA vaccines (source: doi_2321994). The use of fluorescently conjugated secondary antibodies, such as the HyperFluor™ 488 Goat Anti-Human IgG, enables multiplexing and improved sensitivity compared to chromogenic detection systems. This reagent is particularly suited for workflows where high signal-to-noise and multiplexed detection are required, such as in the evaluation of broad-spectrum neutralizing antibody responses following SARS-CoV-2 vaccination (source: internal_article).

    Mechanism of Action of HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody is generated by immunizing goats with purified human IgG, followed by affinity purification using antigen-coupled agarose beads. The purified antibody is polyclonal, recognizing epitopes on both the heavy and light chains of human IgG. Alexa Fluor 488 is covalently attached to the antibody, allowing for excitation at 495 nm and emission at 519 nm (source: product_spec). Upon binding to primary human IgG antibodies, multiple labeled secondary antibodies can bind, leading to strong signal amplification in detection systems (source: internal_article). This amplification is critical for detecting low-abundance targets in complex biological samples.

    Evidence & Benchmarks

    • Affinity-purified polyclonal antibodies demonstrate minimal cross-reactivity with non-human immunoglobulins, reducing background in multiplexed assays (source: product_spec).
    • Alexa Fluor 488 conjugation provides high photostability and quantum yield, enabling detection down to single-molecule levels in immunofluorescence (source: internal_article).
    • In translational vaccine studies, secondary antibody-based detection of human IgG is central for quantifying immune responses to mRNA vaccines, as demonstrated in preclinical models of SARS-CoV-2 (Jing Lu et al., DOI:10.1080/22221751.2024.2321994).
    • Stability of the antibody conjugate is maintained for at least 12 months at -20°C in the presence of 23% glycerol and preservatives, with no significant loss of fluorescence (source: product_spec).
    • Benchmarking across multiple platforms (WB, ICC/IF, IHC, ELISA, flow cytometry) confirms high reproducibility and consistent signal (source: internal_article).

    Applications, Limits & Misconceptions

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody is validated for use in:

    • Immunofluorescence (IF/ICC) – as a fluorescent secondary antibody for immunofluorescence, enabling multiplexed detection of human antibodies in cell and tissue samples.
    • Western blotting – as a Western blot secondary antibody, allowing sensitive detection of target proteins via human primary antibodies.
    • Immunohistochemistry (IHC-Fr/IHC-P) – for detecting human IgG in both frozen and formalin-fixed, paraffin-embedded tissues.
    • Flow cytometry – as a flow cytometry secondary antibody, providing robust fluorescence for cell-surface or intracellular labeling.
    • ELISA – for sensitive, quantitative detection of human IgG in microplate-based assays.

    For a detailed guide on optimizing these applications, see "Optimizing Immunoassays with HyperFluor 488 Goat Anti-Human IgG", which expands on protocol troubleshooting beyond the scope of this dossier.

    Common Pitfalls or Misconceptions

    • Not suitable for direct detection of primary antibodies from non-human species; cross-reactivity with non-human IgG is minimized but not eliminated (source: workflow_recommendation).
    • Signal intensity may decrease if repeated freeze-thaw cycles are performed; aliquoting is recommended for long-term storage (source: product_spec).
    • Fluorescence can be lost upon prolonged exposure to light; storage in the dark is essential (source: product_spec).
    • Background may occur if blocking and washing steps are insufficient, especially in high-sensitivity immunoassays (source: workflow_recommendation).
    • Alexa Fluor 488 may overlap with other fluorophores in multi-color experiments; appropriate compensation controls are required (source: workflow_recommendation).

    This article builds on "HyperFluor 488 Goat Anti-Human IgG Antibody: Precision and Sensitivity" by providing expanded evidence from recent vaccine studies, and clarifies real-world application limits not addressed in prior summaries.

    Workflow Integration & Parameters

    Protocol Parameters

    • Immunofluorescence | 1–10 μg/mL | cell/tissue staining | Ensures optimal signal with minimal background | workflow_recommendation
    • Western blot | 0.5–1 μg/mL | nitrocellulose/PVDF membranes | Achieves clear detection of human IgG-bound proteins | workflow_recommendation
    • Flow cytometry | 1 μg/test (10^5 cells) | cell-surface/intracellular | Provides robust fluorescence for population analysis | workflow_recommendation
    • ELISA | 0.1–1 μg/mL | microplate | Enables sensitive quantification in sandwich or indirect assays | workflow_recommendation
    • Storage | -20°C, avoid freeze-thaw | all formats | Preserves antibody integrity and fluorescence | product_spec
    • Light protection | Store in dark | all applications | Prevents loss of Alexa 488 fluorescence | product_spec

    For advanced strategies to maximize reproducibility, see "Reliable Immunodetection with SKU K1205", which provides scenario-driven Q&A for troubleshooting and enhancing data quality.

    Conclusion & Outlook

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody, supplied by APExBIO, enables sensitive, specific detection of human antibodies in a breadth of immunoassays, supporting research from preclinical vaccine studies to translational immunology (source: doi_2321994). Its robust Alexa Fluor 488 conjugation, validated specificity, and optimized stability advance assay reproducibility and multiplexing in complex biological matrices. Current evidence demonstrates its essential role in quantifying antibody responses and benchmarking novel immunogens, with best practices ensuring minimal background and maximal sensitivity. Future developments will focus on further multiplexing and expanding validated species reactivity only as supported by peer-reviewed evidence (source: internal_article).

    For specifications, protocols, and ordering, visit the official product page.